{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:41:21Z","timestamp":1781070081443,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.exer.2021.108824","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T04:00:44Z","timestamp":1635912044000},"page":"108824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Strengthened rebamipide ocular nanoformulation to effectively treat corneal alkali burns in mice through the HMGB1 signaling pathway"],"prefix":"10.1016","volume":"213","author":[{"given":"Qiqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0301-8305","authenticated-orcid":false,"given":"Xianggen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108824_bib1","doi-asserted-by":"crossref","first-page":"118573","DOI":"10.1016\/j.ijpharm.2019.118573","article-title":"Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel in rabbit eyes","volume":"569","author":"Alshamsan","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2021.108824_bib2","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1167\/iovs.10-6099","article-title":"The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes","volume":"52","author":"Andres-Guerrero","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108824_bib3","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1167\/iovs.10-6338","article-title":"Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers","volume":"52","author":"Andres-Guerrero","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108824_bib4","doi-asserted-by":"crossref","first-page":"120364","DOI":"10.1016\/j.ijpharm.2021.120364","article-title":"A polymeric aqueous tacrolimus formulation for topical ocular delivery","volume":"599","author":"Badr","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2021.108824_bib5","doi-asserted-by":"crossref","first-page":"111152","DOI":"10.1016\/j.colsurfb.2020.111152","article-title":"Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: a novel use as an anti-inflammatory agent in topical drug delivery","volume":"193","author":"Barone","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.exer.2021.108824_bib6","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.2147\/OPTH.S186074","article-title":"Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study","volume":"12","author":"Burillon","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108824_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/0271-3683(200002)2021-DFT085","article-title":"Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells","volume":"20","author":"De Saint Jean","year":"2000","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.ijbiomac.2020.07.306","article-title":"Polypeptide and glycosaminoglycan polysaccharide as stabilizing polymers in nanocrystals for a safe ocular hypotensive effect","volume":"162","author":"Donia","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.exer.2021.108824_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.ijbiomac.2019.10.219","article-title":"Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: formulation, characterization and pharmacodynamic study","volume":"152","author":"Dubey","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.exer.2021.108824_bib10","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1167\/iovs.05-0495","article-title":"Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance","volume":"47","author":"Enriquez de Salamanca","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108824_bib11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/archopht.1992.01080190090035","article-title":"What is actually stained by rose bengal?","volume":"110","author":"Feenstra","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108824_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208198","article-title":"Polyvinyl alcohol-iodine induced corneal epithelial injury in vivo and its protection by topical rebamipide treatment","volume":"13","author":"Fukuda","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108824_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00210-017-1370-7","article-title":"The potential curative effect of rebamipide in hepatic ischemia\/reperfusion injury","volume":"390","author":"Gendy","year":"2017","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.exer.2021.108824_bib14","doi-asserted-by":"crossref","first-page":"108191","DOI":"10.1016\/j.exer.2020.108191","article-title":"Germinal peptide eye drops promote corneal wound healing and decrease inflammation after alkali injury","volume":"199","author":"Guan","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib15","first-page":"113","article-title":"Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes","volume":"9","author":"Hayashi","year":"2016","journal-title":"Int. Med. Case Rep. J."},{"key":"10.1016\/j.exer.2021.108824_bib16","doi-asserted-by":"crossref","first-page":"108364","DOI":"10.1016\/j.exer.2020.108364","article-title":"Expression profiles and potential corneal epithelial wound healing regulation targets of high-mobility group box 1 in diabetic mice","volume":"202","author":"Hou","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib17","doi-asserted-by":"crossref","first-page":"108454","DOI":"10.1016\/j.exer.2021.108454","article-title":"Glycyrrhizin micelle as a genistein nanocarrier: synergistically promoting corneal epithelial wound healing through blockage of the HMGB1 signaling pathway in diabetic mice","volume":"204","author":"Hou","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib18","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ijbiomac.2019.06.199","article-title":"Sulfated modification enhanced the antioxidant activity of Mesona chinensis Benth polysaccharide and its protective effect on cellular oxidative stress","volume":"136","author":"Huang","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.exer.2021.108824_bib19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2174\/1567201816666190313155117","article-title":"Molecular dynamics simulations of glycyrrhizic acid aggregates as drug-carriers for paclitaxel","volume":"16","author":"Hussain","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.exer.2021.108824_bib20","doi-asserted-by":"crossref","first-page":"119101","DOI":"10.1016\/j.ijpharm.2020.119101","article-title":"Enhanced penetration and anti-psoriatic efficacy of curcumin by improved smartPearls technology with the addition of glycyrrhizic acid","volume":"578","author":"Jin","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2021.108824_bib21","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10480","article-title":"Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase","volume":"8","author":"Kandeel","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.exer.2021.108824_bib22","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1167\/iovs.12-11294","article-title":"Protection of human corneal epithelial cells from TNF-alpha-induced disruption of barrier function by rebamipide","volume":"54","author":"Kimura","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108824_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","article-title":"A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye","volume":"120","author":"Kinoshita","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108824_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","article-title":"Nuclear Factor-kappaB: central regulator in ocular surface inflammation and diseases","volume":"10","author":"Lan","year":"2012","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108824_bib25","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3109\/02713683.2015.1133834","article-title":"The wound healing effects of adiponectin eye drops after corneal alkali burn","volume":"41","author":"Li","year":"2016","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","article-title":"Progress in corneal wound healing","volume":"49","author":"Ljubimov","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/pharmaceutics12020155","article-title":"Novel sustained-release drug delivery system for dry eye therapy by rebamipide nanoparticles","volume":"12","author":"Nagai","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exer.2021.108824_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.exer.2016.07.003","article-title":"Size effect of rebamipide ophthalmic nanodispersions on its therapeutic efficacy for corneal wound healing","volume":"151","author":"Nagai","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib29","doi-asserted-by":"crossref","first-page":"108363","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2015.02.012","article-title":"Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation","volume":"752","author":"Pittala","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2021.108824_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/09273949709085057","article-title":"Trauma and alkali burns induce distinct patterns of cytokine gene expression in the rat cornea","volume":"5","author":"Planck","year":"1997","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.exer.2021.108824_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/10717544.2016.1228715","article-title":"Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats","volume":"24","author":"Radwan","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.exer.2021.108824_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jconrel.2021.03.035","article-title":"Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models","volume":"333","author":"Rebibo","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.exer.2021.108824_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108824_bib35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10384-008-0536-8","article-title":"Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing","volume":"52","author":"Sakimoto","year":"2008","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108824_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000369201","article-title":"Alkali burn treated with 2% rebamipide ophthalmic suspension: a case report","volume":"5","author":"Sasaki","year":"2014","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.exer.2021.108824_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.survophthal.2017.09.005","article-title":"Treatment of acute ocular chemical burns","volume":"63","author":"Sharma","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108824_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10565-008-9076-8","article-title":"Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment culture","volume":"25","author":"Shen","year":"2009","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.exer.2021.108824_bib39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/jop.2020.0105","article-title":"Effects of glycyrrhizin treatment on diabetic cornea","volume":"37","author":"Somayajulu","year":"2021","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2021.108824_bib40","first-page":"335","article-title":"Glycyrrhizic acid exerts protective effects against hypoxia\/reoxygenation-induced human coronary artery endothelial cell damage by regulating mitochondria","volume":"20","author":"Tang","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.exer.2021.108824_bib41","doi-asserted-by":"crossref","first-page":"108539","DOI":"10.1016\/j.exer.2021.108539","article-title":"PLGA nanoparticles containing Lingzhi extracts rescue corneal epithelial cells from oxidative damage","volume":"206","author":"Tsai","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib42","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.1021\/acs.jpcb.8b07515","article-title":"Investigation of physiological properties of transglycosylated stevia with cationic surfactant and its application to enhance the solubility of rebamipide","volume":"122","author":"Uchiyama","year":"2018","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.exer.2021.108824_bib43","doi-asserted-by":"crossref","first-page":"115356","DOI":"10.1016\/j.carbpol.2019.115356","article-title":"Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone","volume":"227","author":"Xu","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.exer.2021.108824_bib44","doi-asserted-by":"crossref","first-page":"108313","DOI":"10.1016\/j.exer.2020.108313","article-title":"Preparation and in vitro\/in vivo evaluations of novel ocular micelle formulations of hesperetin with glycyrrhizin as a nanocarrier","volume":"202","author":"Zhang","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108824_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2021.02.025","article-title":"FRET imaging revealed that nanocrystals enhanced drug oral absorption by dissolution rather than endocytosis: a case study of coumarin 6","volume":"332","author":"Zhang","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.exer.2021.108824_bib46","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s13346-020-00859-5","article-title":"A multicomponent-based microemulsion for boosting ovarian cancer therapy through dual modification with transferrin and SA-R6H4","volume":"11","author":"Zhao","year":"2020","journal-title":"Drug Deliv Transl Res"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521003900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521003900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:13:52Z","timestamp":1757999632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521003900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":46,"alternative-id":["S0014483521003900"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108824","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strengthened rebamipide ocular nanoformulation to effectively treat corneal alkali burns in mice through the HMGB1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108824"}}